With flu season approaching, we asked Dr. Troy Sutton, one of VIDO's newest scientists, to help answer some common questions about flu vaccines. Troy brings years of experience studying influenza viruses and developing vaccines, and he's sharing his expertise to help separate fact from fiction.
VIDO has recruited three scientists from around the world to strengthen animal health research in emerging influenza, livestock vaccines and swine immunity.
Learn what CL4 means, why Canada needs this research capacity and how these specialized facilities operate safely.
Artificial intelligence (AI), supercomputers and advanced modelling are changing what’s possible in infectious disease research and vaccine development.
Two VIDO researchers have received more than $2.6 million through the Canadian Institutes of Health Research (CIHR) Project Grant competition to advance research on emerging viruses. Their work will strengthen infectious disease preparedness by accelerating vaccine development and improving understanding of how viruses move between wildlife and people.
VIDO has resumed research in its high-containment facility following the successful completion of federal recertification and planned facility upgrades.
Scientists at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan (USask) are researching solutions to infectious diseases that affect pigs, pork producers and the broader food system.
VIDO’s new agreement with ERINHA positions Saskatchewan as the North American gateway to a leading international network advancing research on high-consequence infectious diseases.
During the work week, Cam Ewart serves as the director of facilities at one of the most advanced high-security infectious disease research facilities in the world.
The University of Saskatchewan (USask) is honouring Dr. Wendy Roy (PhD) with its top academic award of Distinguished Researcher for 2026.
Dr. Neeraj Dhar (PhD), principal scientist at the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO), is looking to better understand immune responses to specific diseases like tuberculosis — a disease that targets the respiratory system — and the therapies being developed to combat them.
From cutting‑edge preclinical models to ambitious next‑generation vaccines, researchers at VIDO are working with CEPI to help the world move faster - and smarter - when the next pandemic threat emerges.
As Canadians begin spring cleaning, an often-overlooked health risk can surface alongside the dust. Illness caused by hantavirus is rare but serious, and researchers at VIDO are working to better understand these viruses and reduce the risk of human infection.
A new study has revealed that while SARS-CoV-2 can weaken part of the body’s early immune response, it may also unintentionally trigger another defense that helps cells fight back.
Canada’s ability to respond to emerging infectious diseases depends not only on cutting-edge research, but on the development of a strong, well-trained scientific workforce.
From developing new vaccines to uncovering drug targets, researchers at VIDO are working to combat tuberculosis, a persistent global health threat that remains one of the leading infectious killers worldwide.
VIDO reflects on its response to the COVID-19 pandemic and how that work continues to shape Canada’s preparedness for future health threats.
Whether partners are at an early-stage biotech building their first vaccine candidate or an established company expanding their infectious disease pipeline, progress depends on one thing: the right partner that can transform promising science to proven results.
Pandemic preparedness has never been more important, and researchers at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan (USask) are exploring new research and response strategies with the support of government funding.
The Vaccine Development Centre at USask’s VIDO provides the expertise and infrastructure to ensure Canada is ready to respond quickly to emerging health threats and support national security.
Funding from the provincial and federal government is enabling VIDO to advance animal health research and engagement with livestock producers across Saskatchewan.
